Skip to content

Interest Income at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
$233M+14.8%
ClearPoint Neuro logo
ClearPoint NeuroCLPT
$351K+132%
Charles River Laboratories logo
Charles River LaboratoriesCRL
$1.03M-26.4%
West Pharmaceutical Services logo
West Pharmaceutical ServicesWST
$5.1M+24.4%
Labcorp Holdings logo
Labcorp HoldingsLH
$12.2M+87.7%
BioCryst Pharmaceuticals logo
BioCryst PharmaceuticalsBCRX
$2.26M-25.4%

Other financials

Income statement

See full
Revenue$23.2M-36.4%
Gross profit$4.5M-68.1%
Operating income-$4.7M
Net income-$15.0M-1,206%
EPS (diluted)-$0.43-1,333%

Balance sheet

See full
Cash & equivalents$20.8M+152%
Total debt$156.9M+1,310%
Total equity-$28.4M-2,229%
Total assets$225.5M-5.8%

Cash flow

See full
Operating cash flow$4.7M
CapEx$1.1M-46.7%
Free cash flow$3.6M

Valuation

See full
Market cap$196.92M-35.4%
Enterprise value$333.06M+8.3%
P/S1.6×+0.5×

Profitability

See full
Gross margin31.3%-1.4pp
Operating margin-14.5%-2.2pp
Net margin-30%
FCF margin-36.4%

Returns & leverage

See full
Return on equity-612.1%
Debt / equity8.3×-1.5×
Current ratio3.8×+0.9×

Where this comes from

Reported directly by Lifecore Biomedical, Inc. in its filing.

Tagged under the XBRL concept us-gaap:InvestmentIncomeInterest.

The official record: Lifecore Biomedical, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Lifecore Biomedical, Inc.'s interest income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Lifecore Biomedical, Inc.'s interest income?
Lifecore Biomedical, Inc. (LFCR) reported interest income of $128K in Q1 2026.
What does interest income mean?
Income earned from interest-bearing assets including cash deposits, money market funds, treasury securities, corporate bonds, and customer financing receivables.